Zenith Healthcare

Zenith Healthcare EPS

Earnings per Share (EPS) of Zenith Healthcare (530665.BO) as of Oct 27, 2026.

EPS

0.00INR

YoY

-92.39%

Last updated:

Earnings per Share (EPS) of Zenith Healthcare is 2026 0.00 INR. Earnings per Share (EPS) of Zenith Healthcare was 2025 0.01 INR. It decreases by -92.39% lower compared to the previous year.

The Zenith Healthcare EPS history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EPS
Date
EPS
Jan 1, 2019
0.03 INR
Jan 1, 2020
0.11 INR
Jan 1, 2021
0.08 INR
Jan 1, 2022
0.06 INR
Jan 1, 2023
0.01 INR
Jan 1, 2024
0.04 INR
Jan 1, 2025
0.01 INR
Jan 1, 2026
0.00 INR
The Zenith Healthcare EPS history
YEAREPSYoY
0.00INR-92.39%
0.01INR-67.08%
0.04INR+161.57%
0.01INR-74.96%
0.06INR-29.39%
0.08INR-22.22%
0.11INR+314.41%
0.03INR-50.12%
0.05INR-279.74%
-0.03INR-50.97%
-0.06INR+28.45%
-0.04INR-10.58%
-0.05INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Zenith Healthcare Stock analysis

What does Zenith Healthcare do? Zenith Healthcare Ltd. manufactures pharmaceutical formulations including tablets, capsules, oral liquids, and injections for various therapeutic segments. The company sells products such as Roxythromycin Tablets, Ciprofloxacin Tablets, Azithromycine Dihydrate Suspension, Azithromycin Oral Suspension under antibiotics and anti-infective, Ranitidine Hydrochloride Tablets for gastrointestinal, Lisinopril Tablets for cardiovascular system, and Paracetamol and Aceclofenac Tablets for analgesic/anti-inflammatory categories. It also provides contract manufacturing services for all dosage forms. The company's primary customers are healthcare providers and pharmacies that purchase its branded pharmaceutical products. Zenith Healthcare targets therapeutic segments including antibiotics, gastrointestinal, cardiovascular, analgesic, and others as specified in its product portfolio. Its contract manufacturing services are offered to other pharmaceutical companies seeking production capabilities. Zenith Healthcare's revenue streams come from direct sales of its branded pharmaceutical products across multiple therapeutic segments and from contract manufacturing agreements. The company focuses on delivering products in key therapeutic areas such as antibiotics, gastrointestinal, cardiovascular, and analgesic markets where it has established product lines. Zenith Healthcare is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Zenith Healthcare stock

On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Zenith Healthcare since 2006 – with annual values, charts, and detailed analysis.

Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.

EPS = Net Income / Shares Outstanding

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Zenith Healthcare

All Key Metrics — Zenith Healthcare